Evidence map›Paper›PMID 26541195›Full record

ArticleJournal of translational medicine2015

The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results.

Cristian Pattaro, Martin Gögele, Deborah Mascalzoni, Roberto Melotti, Christine Schwienbacher, Alessandro De Grandi, Luisa Foco, Yuri D'Elia, Barbara Linder, Christian Fuchsberger and 11 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Clinical and Metabolic Signatures ofKidney international reports · 2025
    Article
  13. Focus on a CKD-Associated Locus:Kidney international reports · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Cristian PattaroCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy. cristian.pattaro@eurac.edu.
Martin GögeleCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Deborah MascalzoniCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Roberto MelottiCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Christine SchwienbacherCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Alessandro De GrandiCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Luisa FocoCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Yuri D'EliaCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Barbara LinderCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Christian FuchsbergerCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Cosetta MinelliRespiratory Epidemiology, Occupational Medicine and Public Health, National Heart and Lung Institute, Imperial College, London, UK.
Clemens EggerCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Lisa S KofinkCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Stefano ZanigniFunctional MR Unit, Policlinico S. Orsola, Malpighi Bologna, Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
Torsten SchäferDermatological Practice, Kirchplatz 3, 87059, Immenstadt, Germany.
Maurizio F FacherisThe Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA.
Sigurður V SmárasonCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Alessandra RossiniCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Andrew A HicksCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Helmuth WeissCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy.
Peter P PramstallerCenter for Biomedicine, European Academy of Bolzano/Bozen (EURAC) (Affiliated to the University of Lübeck, Lübeck, Germany), Via Galvani 31, 39100, Bolzano/Bozen, Italy. peter.pramstaller@eurac.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Cooperative Health Research In South Tyrol (CHRIS) study is a population-based study with a longitudinal lookout to investigate the genetic and molecular basis of age-related common chronic conditions and their interaction with life style and environment in the general population. All adults of the middle and upper Vinschgau/Val Venosta are invited, while 10,000 participants are anticipated by mid-2017. Family participation is encouraged for complete pedigree reconstruction and disease inheritance mapping. After a pilot study on the compliance with a paperless assessment mode, computer-assisted interviews have been implemented to screen for conditions of the cardiovascular, endocrine, metabolic, genitourinary, nervous, behavioral, and cognitive system. Fat intake, cardiac health, and tremor are assessed instrumentally. Nutrient intake, physical activity, and life-course smoking are measured semi-quantitatively. Participants are phenotyped for 73 blood and urine parameters and 60 aliquots per participant are biobanked (cryo-preserved urine, DNA, and whole and fractionated blood). Through liquid-chromatography mass-spectrometry analysis, metabolite profiling of the mitochondrial function is assessed. Samples are genotyped on 1 million variants with the Illumina HumanOmniExpressExome array and the first data release including 4570 fully phenotyped and genotyped samples is now available for analysis. Participants' follow-up is foreseen 6 years after the first visit. The target population is characterized by long-term social stability and homogeneous environment which should both favor the identification of enriched genetic variants. The CHRIS cohort is a valuable resource to assess the contribution of genomics, metabolomics, and environmental factors to human health and disease. It is awaited that this will result in the identification of novel molecular targets for disease prevention and treatment.

Indexed as

Genetic Predisposition to DiseaseHealth StatusLife StyleAdolescentAdultAgedBiological Specimen BanksBlood ProteinsEnvironmentEthics, MedicalExomeFemaleFollow-Up StudiesGenotypeHumansItalyBlood Proteins

Identifiers

PMID26541195
PMCPMC4635524

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.